
SULTAZYX 375 Tablets by Kivonyx Healthcare Pvt. Ltd. contain Sultamicillin 375 mg, an oral antibiotic formulation used for treating selected bacterial infections caused by susceptible microorganisms. Sultamicillin is converted into Ampicillin and Sulbactam after absorption. Ampicillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Sulbactam inhibits certain beta-lactamase enzymes responsible for antibiotic resistance. SULTAZYX 375 may be prescribed for selected respiratory tract, throat, ear, urinary tract, skin, and soft tissue infections when clinically appropriate. Available in blister strip packaging, this medicine should be taken strictly according to a registered medical practitioner's prescription, considering bacterial susceptibility, infection severity, kidney function, allergy history, potential adverse effects, and recommended treatment duration.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.